PRiCAN Symposium 2025
Join us at our 2nd annual PRiCAN Research symposium, a pivotal event dedicated to advancing primary care cancer research. This one-day event will explore the future of precision prevention and pragmatic cancer trials in primary care, featuring expert speakers, panel discussions, and a hands-on trial design workshop. A key opportunity to network and shape the future of cancer research in primary care.
Primary care cancer research is at the forefront of improving how we prevent, detect, and manage cancer within primary healthcare settings – where patients often initiate their medical journey. Our symposium highlights the significance of primary care in the context of cancer, aiming to revolutionise the patient experience from the outset of suspicion, through diagnosis and throughout the continuum of care.
Renowned experts and emerging talents alike will present their findings, fostering interdisciplinary collaboration and a spirit of intellectual curiosity.
Join us at this PRiCAN research symposium and be a part of this transformative discussion, where we explore innovative approaches, and share groundbreaking insights.
Together, we are shaping the future of primary care in the fight against cancer! Don’t miss out on this opportunity to be at the forefront of change and discovery!
Keynote Speakers
Confirmed speakers include:
Prof Karen Brown, Professor of Translational Cancer Research, Director Leicester Cancer Research Centre, University of Leicester
Karen is director of the Leicester Cancer Research Centre and joint lead of the Leicester Experimental Cancer Medicine Centre. She established and is co-chair of the UK Therapeutic Cancer Prevention Network and represents this network on the steering group of the Cancer Prevention Europe Consortium.
Karen’s research focusses on the discovery and preclinical development of agents for the prevention of cancer in populations at increased risk. She works to optimise the translation of these therapies to the clinic where she conducts early and late phase trials. Karen is currently leading COLO-PREVENT, a world-first prevention trial platform that will investigate the ability of resveratrol, aspirin and metformin to prevent colorectal polyps in high-risk patients. This trial is funded by Cancer Research UK and will be conducted across 60 sites in England and Wales.
Karen sits on several national and international grant panels and is currently a member of the Cancer Research UK Prevention and Population Research Committee and Vice-Chair of an Expert Review Panel for this committee. She is a member of the World Cancer Research Fund International Regular Grant Programme Panel and Breast Cancer Now Grants Committee. Karen is also a former President of the United Kingdom Environmental Mutagen Society and currently sits on the committee as past-president.
Location: The Albert Lecture Theatre, RCSI, 123 St Stephen’s Green
Date: APRIL 3rd, 2025
For more information please email prican@rcsi.com